Max Nisen is a Bloomberg Gadfly columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider.

Good morning! This is Fly Charts, the daily charts-only newsletter from Gadfly; sign up here. From oil disunity to biotech's platform mania, here are four charts that explain what you need to know in business today. 

Disunited Nations
America and the world are more divided than they have been in years -- in crude oil prices.
Source: Bloomberg
Something to Celebrate
U.S. stock records have soaked up all of the attention, but there's been a lot more to cheer about elsewhere in the world.
Source: Bloomberg
Note: Indexed to 100.
Platform Fever
Investors buying into Alnylam's share surge may be reading too much into a single drug trial’s success.
Source: Bloomberg
The FDA's planned nicotine cuts and other pressures mean it's change or die time for big tobacco.
Source: Bloomberg

And don't miss Marcus Ashworth on Pennon's work of interest rate management art: "On Monday it successfully bought back most of its 300 million pounds ($405.7 million) of 6.75 percent perpetual bonds. It also issued the same amount of perpetual bonds with a much lower coupon, at 2.875 percent. Corporate nirvana. The lack of a credit rating paled in significance to the allure of lending to a borrower from a safe business with a steady cash flow. In fact initial price talk was for a coupon of about 3.25 percent, but the company was able to get something smaller. The price has since risen above par, and the yield is now about 2.6 percent. For an unsecured bond that technically never has to be redeemed, that's not a lot. But these are the times we live in."

This column does not necessarily reflect the opinion of Bloomberg LP and its owners.

To contact the author of this story:
Max Nisen in New York at

To contact the editor responsible for this story:
Mark Gongloff at